6 Innovation Areas Liver Cancer Specialists Need to Master
6 Innovation Areas Liver Cancer Specialists Need to Master As fellows and translational researchers/HCPs [...]
Read moreILCA e-Update Issue n°30 – October 2020
Introduction Dear members, colleagues and friends, Welcome to another edition of the ILCA e-Newsletter. [...]
Read moreLiver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system
Intrahepatic cholangiocarcinoma (iCCA) with liver metastases (LM) are perceived to have a poor prognosis [...]
Read moreILCA School in Liver Cancer is virtual this December!
Innovations in Primary Liver Cancer Book your seat today! Special registration rates for trainees, [...]
Read moreLiver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria: A Systemic Review and Meta-analysis
Systematic Review and Meta-analysis that reviewed a total of 7 RCTs and 18 matched NRTs, involving 2865 [...]
Read moreProton beam radiotherapy versus radiofrequency ablation for the treatment of small hepatocellular carcinoma
This monocentric non-inferiority randomized controlled trial has compared proton beam radiotherapy (72 [...]
Read more
Thank you for attending #ILCA20Virtual!
It was a great pleasure welcoming you to our first-ever virtual conference and we hope that you have [...]
Read moreHighlights of the EASL Digital International Liver Congress ILC2020
In this short newsletter, the ILCA Communications Committee highlighted a selection of studies on primary [...]
Read moreSerum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers
As biliary tract cancer (BTC) patients typically survive less than one year on standard-of-care [...]
Read more#ILCA20Virtual -11/09 Newsletter
Count me in! Sequencing and Stratification of Systemic Therapy in HCC Symposium Participate [...]
Read more